Mars Veterinary Executive and Leadership Team

Jan Freudenberg, the Chief Financial Officer at Mars Veterinary, directs financial strategy and operations across the organization. Freudenberg oversees budgeting, financial planning, and resource allocation, ensuring fiscal health and supporting the company's global expansion initiatives. This leadership position involves managing financial risks and identifying opportunities for revenue growth and operational efficiency. By optimizing financial processes, Jan Freudenberg contributes directly to the sustainability and strategic objectives of Mars Veterinary Health. The focus remains on robust financial management to support the mission of improving pet health worldwide.

Tatsuhiko Miyamoto, the Chief Financial Officer, At Vca (Japan) at Mars Veterinary, manages the financial landscape for VCA operations within Japan. Miyamoto's responsibilities encompass financial reporting, compliance, and the strategic deployment of capital to enhance veterinary services in the Japanese market. This role requires a deep understanding of local financial regulations and market dynamics. By ensuring sound financial practices, Tatsuhiko Miyamoto supports the growth and operational excellence of VCA clinics in Japan, aligning with the broader Mars Veterinary Health mission to advance pet care globally. The objective is to drive financial performance and support veterinary professionals.

Edwin Stedem, the Global Chief Financial Officer, Mars Veterinary Health at Mars Veterinary, architects the overarching financial strategy for the entire global veterinary health organization. Stedem guides financial planning, investment decisions, and fiscal management across thousands of clinics worldwide, ensuring robust economic health and sustainable growth. This critical role involves overseeing global financial operations, managing complex international accounting standards, and driving initiatives that enhance profitability and operational efficiency. By providing strategic financial leadership, Edwin Stedem directly supports the company's mission to create a better world for pets and veterinary professionals, leveraging financial insights to fuel innovation and expand access to high-quality care across all regions. Stedem's oversight ensures the financial stability necessary for global impact.

Molly McAllister, the Chief Medical Officer at Mars Veterinary, leads the clinical vision and medical standards across the global network of veterinary practices. McAllister champions the advancement of veterinary medicine, focusing on evidence-based practices and the integration of scientific breakthroughs to elevate pet health outcomes. This position involves guiding clinical protocols, fostering professional development for veterinarians, and ensuring the highest quality of patient care. By setting medical direction, Molly McAllister directly contributes to the company's mission of improving the wellbeing of pets and supporting veterinary professionals worldwide. The emphasis is on clinical excellence and innovation in veterinary care delivery across all operational geographies.

Todd Tams, the Chief Medical Officer, External Affairs at Mars Veterinary, directs the strategic engagement with external medical communities and stakeholders. Tams focuses on building relationships, fostering collaborations, and representing the company's medical expertise on a global scale. This role involves communicating advancements in veterinary science and advocating for best practices in pet healthcare. By managing external medical affairs, Todd Tams enhances the company's reputation and influence within the veterinary industry, supporting the broader mission of improving pet health and wellbeing. The objective is to ensure Mars Veterinary Health remains at the forefront of medical innovation and professional development, driving positive impact through strategic external partnerships.